Dasatinib and docetaxel in advanced prostate cancer

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1248-1249
Number of pages2
JournalThe Lancet Oncology
Volume14
Issue number13
DOIs
StatePublished - Dec 2013

Fingerprint

docetaxel
Castration-Resistant Prostatic Neoplasms
Antineoplastic Combined Chemotherapy Protocols
Prostatic Neoplasms
Dasatinib

ASJC Scopus subject areas

  • Oncology

Cite this

Dasatinib and docetaxel in advanced prostate cancer. / Lara, Primo N; Evans, Christopher P.

In: The Lancet Oncology, Vol. 14, No. 13, 12.2013, p. 1248-1249.

Research output: Contribution to journalArticle

@article{a5b3168e349f45d985eae1647709ddd2,
title = "Dasatinib and docetaxel in advanced prostate cancer",
author = "Lara, {Primo N} and Evans, {Christopher P}",
year = "2013",
month = "12",
doi = "10.1016/S1470-2045(13)70500-X",
language = "English (US)",
volume = "14",
pages = "1248--1249",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "13",

}

TY - JOUR

T1 - Dasatinib and docetaxel in advanced prostate cancer

AU - Lara, Primo N

AU - Evans, Christopher P

PY - 2013/12

Y1 - 2013/12

UR - http://www.scopus.com/inward/record.url?scp=84888129102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888129102&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(13)70500-X

DO - 10.1016/S1470-2045(13)70500-X

M3 - Article

C2 - 24211164

AN - SCOPUS:84888129102

VL - 14

SP - 1248

EP - 1249

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 13

ER -